A landmark moment in the world’s efforts to respond to the Ebola crisis is set to begin in the Democratic Republic of the Congo as clinical trials of an experimental therapy begin; after the National Rifle Association (NRA) posted a mocking tweet to physicians about gun violence, doctors responded in kind on Twitter; House Minority Leader Nancy Pelosi, D-California, said she is "staying on as Speaker" to protect the Affordable Care Act (ACA).
A landmark moment in the world’s efforts to respond to the Ebola crisis, as well as future crises, is set to begin in the Democratic Republic of the Congo, STAT reported. Health officials are preparing to launch a clinical trial designed to test whether experimental Ebola therapies improve patients’ chances of survival, but the trial will be complicated given the violent environment. The randomized controlled trial will compare 3 different antibody treatments and an antiviral drug to each other, rather than involving a placebo.
After the National Rifle Association (NRA) posted a mocking tweet to physicians about gun violence—just hours before a man opened fire in a California bar killing 12 people—doctors responded in kind on Twitter. The NRA suggested that “anti-gun doctors should stay in their lane” when it comes to gun control. Using the hashtag #ThisIsOurLane, physicians wrote about pulling bullets out of bodies and telling loved ones their family members were dead, often posting graphic photos, NPR reported. The NRA has long advocated to prevent the CDC from conducting research on gun violence.
House Minority Leader Nancy Pelosi, D-California, said on CBS's "Face the Nation that she is "staying on as Speaker" to protect the Affordable Care Act. Pelosi formally announced her bid for the top House leadership role after the Democrats won control of the House in last week's midterms. She also called on Republicans in Congress to join Democrats in working to protect pre-existing conditions.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More